TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NVAX

Novavax Inc

Healthcare · Biotechnology

10.50$ -1.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -245 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NVAX
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-3.3 -4.2 -3.6 -3.7 -10 -4.6 -21 -18 -30 -5.8 -15 -27 -24 -33 -33 -24 -18 -45 -67 -126 -255 -139 -185 -137 -43 323 -416 -714 -87 -245
0.3 0.3 0.3 0.4 0.6 3.5 1.1 1.2 3.1 3.5 2.7 -1.0 0.9 1.2 1.4 1.6 1.7 2.6 4.4 6.0 8.5 9.8 8.2 5.7 4.9 13 29 41 48 28
– – – – – – 0.1 – 0.1 0.4 2.3 1.8 2.1 1.5 1.3 2.0 2.1 2.5 6.1 13 19 20 18 17 128 184 130 85 48 36
– – – – – – – – – – – – – – – -0.4 1.7 2.9 5.5 14 20 23 11 13 112 176 574 – – –
2.6 -0.5 0.8 0.4 1.5 1.5 0.0 -2.1 2.4 -1.2 2.7 0.6 1.3 2.2 1.7 -5.8 2.5 -0.1 5.1 7.2 -7.5 9.1 -21 -24 12 1,734 -361 -377 48 -888
0.1 0.0 0.2 0.6 0.8 2.3 9.7 2.0 1.6 0.2 1.5 2.0 5.7 0.7 1.6 0.6 4.3 5.8 7.3 18 18 4.2 1.4 1.9 55 57 93 59 13 5.6
-0.8 0.3 -0.4 -0.8 -13 -5.7 -9.7 -1.9 -1.6 -0.2 -67 25 30 2.4 -21 19 -32 16 -130 -21 28 36 29 38 -378 100 -93 -59 -204 -78
– – 0.2 – – – – – – – – – – – – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – 39 – – – – –
– – -5.0 -0.2 – – – – – – -0.1 – – – – 11 54 130 111 209 3.8 65 103 98 -39 590 – – – -4.8
– – – – – – – – – – – – – – – -0.1 -0.3 0.9 -0.8 -0.8 314 0.0 -96 -96 -96 -128 82 -352 -4.0 33
2.0 5.4 1.2 4.2 38 15 14 44 22 20 57 -0.7 17 42 23 11 54 131 110 208 279 65 103 98 985 462 325 4.5 261 28
-2.1 1.5 -2.8 -0.3 14 5.2 -17 25 -9.8 14 -25 -2.8 23 12 -31 6.0 3.3 102 -87 61 51 -38 -53 0.2 567 880 -179 -765 -39 -289
-3.4 -4.2 -3.8 -4.3 -11 -6.9 -31 -20 -32 -6.0 -16 -29 -30 -34 -34 -24 -23 -51 -74 -144 -274 -143 -186 -138 -97 265 -509 -773 -100 -250

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?